Interpretation of transplant biopsies and immune responses f... : Current Opinion in Organ
Transplantation Interpretation of transplant biopsies and immune responses following Treg cell …

The major current focus on treating rheumatoid arthritis is to put an end to long-term
treatments and instead, specifically block widespread immunosuppression by developing …

Based on successes in preclinical animal transplant models, adoptive cell therapy (ACT)
with regulatory T cells (Tregs) is a promising modality to induce allograft tolerance or reduce …

Adoptive regulatory T cell therapy: challenges in clinical t... : Current Opinion in Organ
Transplantation Adoptive regulatory T cell therapy: challenges in clinical transplantation : Current …

Optimizing regulatory T cells for therapeutic application in... : Current Opinion in Organ
Transplantation Optimizing regulatory T cells for therapeutic application in human organ …

Solid organ transplantation is the treatment of choice for patients with end-stage organ
dysfunction. Despite improvements in short-term outcome, long-term outcome is suboptimal …

With growing number of cases in recent years, composite tissue allotransplantation (CTA)
has been improving the quality of life of patient who seeks reconstruction and repair of …

Graft-versus-host disease (GVHD) is the leading cause of morbidity and mortality after
allogeneic hematopoietic stem cell transplantation (allo-HSCT). Immunomodulation using …

Transplantation is limited by the need for life-long pharmacological immunosuppression,
which carries significant morbidity and mortality. Regulatory T cell (Treg) therapy holds …

Current approaches to prevent or treat transplant rejection, graft-versus-host disease and
severe autoimmunity rely on non-specific immunosuppressive drugs. Ongoing efforts aimed …